Proteus Syndrome
📧 Sign up to get email alerts when something new happens for Proteus Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Study of Proteus Syndrome and Related Congenital Disorders
Clinical trial update noting that the study examining Proteus syndrome and PIK3CA-related overgrowth spectrum is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: MK-7075 (Miransertib) in Proteus Syndrome [Phase 2]
A Phase 2 study of Miransertib (MK-7075) for Proteus Syndrome is currently recruiting, sponsored by the National Human Genome Research Insti…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006) [Phase 2]
This is a Phase 2 clinical trial update on the safety and tolerability of miransertib (MK-7075) in participants with PIK3CA-related overgrow…
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Study of Miransertib (MK-7075) in Participants With PIK3CA-related Overgrowth Spectrum and Proteus Syndrome (MOSAIC) (MK-7075-002) [Phase 1, Phase 2]
Clinical trial update for miransertib in PROS and Proteus Syndrome (MOSAIC) shows the study was terminated; results were posted in 2023.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
The update summarizes early participants' perspectives on informed consent for whole-genome sequencing in an NHGRI-supported study and the i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.